DEF: LivaNova Sets Date for 2025 Annual General Meeting, Outlines Key Proposals

LivaNova PLC announces its 2025 Annual General Meeting (AGM) to be held virtually on June 11, 2025, detailing proposals for shareholder voting, including director elections, executive compensation, and auditor appointments.

Summary

• LivaNova PLC will hold its 2025 Annual General Meeting (AGM) virtually on June 11, 2025.
• Shareholders of record as of April 14, 2025, are eligible to attend and vote.
• The AGM includes voting on the election of ten directors, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP (PwC-US) as the company's independent registered public accounting firm for 2025.
• Shareholders will also vote on approving the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan and the LivaNova PLC 2025 Director Incentive Award Plan.
• The board seeks authorization to allot shares up to a nominal amount of 10,904,831 and to disapply pre-emption rights.
• An advisory vote will be held to approve the UK directors remuneration report and to approve the directors remuneration policy.
• Shareholders will vote to receive and adopt the company's audited UK statutory accounts for the year ended December 31, 2024, and to re-appoint PricewaterhouseCoopers LLP (PwC-UK) as the company's UK statutory auditor for 2025.
• The board seeks authorization to determine the remuneration of the company's UK statutory auditor.

Sentiment

Score: 7

Explanation: The document is neutral in tone, presenting factual information about the upcoming AGM and proposals for shareholder voting. It reflects standard corporate governance procedures and doesn't contain overtly positive or negative sentiment.

Positives

• The board is seeking shareholder input on key governance and compensation matters.
• The company is committed to good corporate governance, promoting long-term shareholder interests and strengthening accountability.
• The board is focused on ensuring a diverse board, highlighting diversity as a key criterion for consideration in the selection of new directors.
• The company has engaged with the majority of its top 30 shareholders, representing over 70% of the company's register as of December 31, 2024.

Risks

• Failure to approve the resolutions could limit the company's flexibility in managing its share capital and compensating its directors and employees.
• Cybersecurity incidents at a supplier, subcontractor, or service provider could materially adversely impact the company.
• The company may not be successful in preventing or mitigating a cybersecurity incident that could have a material adverse effect on the company.

Future Outlook

The company plans to continue exploring initiatives throughout 2025 in furtherance of its sustainability plan.

Industry Context

The document reflects standard corporate governance practices for publicly listed companies, particularly those with a dual listing in the UK and US, including shareholder votes on director remuneration and auditor appointments.

Comparison to Industry Standards

• The proposals outlined in the document are consistent with standard corporate governance practices observed among publicly traded companies, particularly those listed on exchanges like Nasdaq and subject to regulations such as the Companies Act 2006.
• The advisory vote on executive compensation (Say on Pay) is a common practice among US-listed companies, mirroring similar requirements for UK-listed firms regarding director remuneration reports.
• The request for authority to allot shares and disapply pre-emption rights aligns with practices seen in UK-incorporated companies, providing flexibility in capital management.
• The director compensation structure, including cash retainers and equity awards, is comparable to that of peer companies in the medical device industry, as determined by compensation consultants like Pearl Meyer.

Stakeholder Impact

• Shareholders have the opportunity to influence key decisions through voting.
• Employees may be affected by changes to the incentive award plan.
• The company's performance and governance practices impact investor confidence.

Next Steps

• Shareholders to review proxy materials and vote on the proposals.
• Company to hold the AGM on June 11, 2025.
• Company to file the results of the AGM with the SEC.

Key Dates

Keywords

Annual General Meeting, Proxy Statement, Director Elections, Executive Compensation, Share Allotment, Pre-emption Rights, Auditor Appointment, Incentive Award Plan, Corporate Governance, LivaNova